Author

Christopher Crane

OpenAlex ID: A5036651920

A Survey of the Regulatory Requirements for BCS-Based Biowaivers for Solid Oral Dosage Forms by Participating Regulators and Organisations of the International Generic Drug Regulators Programme

2018 · Joy Elizabeth Van Oudtshoorn, Alfredo García-Arieta, et al. · Journal of Pharmacy & Pharmaceutical Sciences · 25

The bioequivalence study design recommendations for immediate-release solid oral dosage forms in the international pharmaceutical regulators programme participating regulators and organisations: differences and commonalities

2024 · Eduardo Agostinho Freitas Fernandes, Joy van Oudtshoorn, et al. · Journal of Pharmacy & Pharmaceutical Sciences · 12

A Survey of the Regulatory Requirements for the Acceptance of Foreign Comparator Products by Participating Regulators and Organizations of the International Generic Drug Regulators Programme

2019 · Alfredo Garcia Arieta, Craig Simon, et al. · Journal of Pharmacy & Pharmaceutical Sciences · 12

The Requirements for Additional Strength Biowaivers for Immediate Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities

2019 · Christopher Crane, Gustavo Mendes Lima Santos, et al. · Journal of Pharmacy & Pharmaceutical Sciences · 11

A Survey of the Regulatory Requirements for the Waiver of In Vivo Bioequivalence Studies of Generic Products in Certain Dosage Forms by Participating Regulators and Organisations of the International Pharmaceutical Regulators Programme

2021 · Alfredo Garcia Arieta, Craig Simon, et al. · Journal of Pharmacy & Pharmaceutical Sciences · 7

Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities

2021 · Matthias Shona Roost, Henrike Potthast, et al. · Journal of Pharmacy & Pharmaceutical Sciences · 5

A survey of regulatory recommendations for waivers of in vivo bioequivalence studies of generic products for certain dosage forms by participating regulators and organisations of the International Pharmaceutical Regulators Programme. Part 2

2025 · Alfredo García-Arieta, Andrew Tam, et al. · Journal of Pharmacy & Pharmaceutical Sciences · 1

Works count: 8

Citation count: 73

H-index: 5

I10-index: 4